Skip to content

HCV Global Access Webinars Series

  • Chad Cipiti

  December 8, 2015 DOWNLOAD: HCV Webinar #1: The Cost of Production for HCV Treatment Slides Presenter: Dr. Andrew Hill, Senior Research Fellow, Department of Pharmacology and Therapeutics, Liverpool University, United Kingdom Description: New HCV drugs, called direct-acting antivirals (DAAs),…

Read more

2013 Symposium: Cascades – Improving TB Care

  • Chad Cipiti

The Treatment Action Group (TAG) “Cascades: Improving TB Care” symposium was held on November 1 at the 2013 International Union World Conference on Lung Health in Paris, France. Cosponsored by TAG, Médecins Sans Frontières (MSF), Partners In Health (PIH), the…

Read more

Tuberculosis Behind the Numbers Video Series

  • Chad Cipiti

Mike Frick of Treatment Action Group (TAG) and Audrey Zhang of Harvard College argue that patient-centered approaches in treatment for drug-resistant and drug-sensitive tuberculosis are needed. View Webinar Lindsay McKenna and Colleen Daniels of Treatment Action Group (TAG) describe the…

Read more

Silent Crisis

  • Chad Cipiti
On January 18, 2013, in Washington, D.C., TAG held a consultation on the domestic TB drug shortage crisis. The meeting was cosponsored by PATH, RESULTS, the Center for Global Health Policy, and the American Thoracic Society.
Read more

Childhood TB Advocacy Meeting Presentations

  • Chad Cipiti

On January 5, 2012, TAG held a Childhood TB Federal Advocacy Meeting in Washington, D.C. The meeting was cosponsored by STOP TB, RESULTS/ACTION, the Center for Global Health Policy, and the American Thoracic Society (ATS). Some of the highlights of the…

Read more

Starting HAART: When to Take the First Step?

  • Chad Cipiti

Starting HAART: When to Take the First Step? 20 July, 2010 Click to view session Presenters included: Steven Deeks (United States) Professor of Medicine, University of California, San Francisco (UCSF) Peter Mugyenyi (Uganda) Director and Founder, Joint Clinical Research Center…

Read more
Back To Top